Defining HIV and SIV Reservoirs in Lymphoid Tissues
Pathogens and Immunity · 14.06.2016 · 1 (1) · 68
DOI: 10.20411/pai.v1i1.100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens and Immunity, online erschienen am 14.06.2016. Verfasst von Claire Deleage und 14 weiteren Autor:innen. Beteiligte Einrichtung: AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702. Die Arbeit wurde bisher 274-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Intramural NIH HHS, CCR NIH HHS.
Abstract (Originalsprache)
A primary obstacle to an HIV-1 cure is long-lived viral reservoirs, which must be eliminated or greatly reduced. Cure strategies have largely focused on monitoring changes in T cell reservoirs in peripheral blood (PB), even though the lymphoid tissues (LT) are primary sites for viral persistence. To track and discriminate viral reservoirs within tissue compartments we developed a specific and sensitive next-generation in situ hybridization approach to detect vRNA, including vRNA+ cells and viral particles (“RNAscope”), vDNA+ cells (“DNAscope”) and combined vRNA and vDNA with immunohistochemistry to detect and phenotype active and latently infected cells in the same tissue section. RNAscope is highly sensitive with greater speed of analysis compared to traditional in situ hybridization. Highly sensitive and specific DNAscope detected SIV/HIV vDNA+ cells, including duplexed detection of vDNA and vRNA or immunophenotypic markers in the same section. Analysis of LT samples from macaques prior to and during combination antiretroviral therapy demonstrated that B cell follicles are an important anatomical compartment for both latent and active viral persistence during treatment. These new tools should allow new insights into viral reservoir biology and evaluation of cure strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- AIDS and Cancer Virus Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
- Department of Microbiology and Immunology, Medical School, University of Minnesota, Minneapolis, MN 55455.
- Pathology and Histotechnology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
- Department of Medicine. Medical School, University of Minnesota, Minneapolis, MN 55455.
- School of Public Health, Division of Biostatistics, University of Minnesota, Minneapolis, MN 55455.
- Division of Experimental Medicine, Department of Medicine, University of California, San Francisco, CA 94110.
Förderung
- NIAID NIH HHS
- Intramural NIH HHS
- CCR NIH HHS
- NCI NIH HHS
Zitieren
APA
Deleage, C., Wietgrefe, S. W., Del Prete, G., Morcock, D. R., Hao, X. P., Piatak, M., Bess, J., Anderson, J. L., Perkey, K. E., Reilly, C., McCune, J. M., Haase, A. T., Lifson, J. D., Schacker, T. W., & Estes, J. D. (2016). Defining HIV and SIV Reservoirs in Lymphoid Tissues. Pathogens and Immunity, 1(1), 68. https://doi.org/10.20411/pai.v1i1.100
Vancouver
Deleage C, Wietgrefe SW, Del Prete G, Morcock DR, Hao XP, Piatak M, et al. Defining HIV and SIV Reservoirs in Lymphoid Tissues. Pathogens and Immunity. 2016;1(1):68. doi:10.20411/pai.v1i1.100
BibTeX
@article{Deleage2016,
author = {Deleage, Claire and Wietgrefe, Stephen W and Del Prete, Gregory and Morcock, David R and Hao, Xing Pei and Piatak, Michael and Bess, Julian and Anderson, Jodi L and Perkey, Katherine E and Reilly, Cavan and McCune, Joseph M and Haase, Ashley T and Lifson, Jeffrey D and Schacker, Timothy W and Estes, Jacob D},
title = {Defining HIV and SIV Reservoirs in Lymphoid Tissues},
journal = {Pathogens and Immunity},
year = {2016},
volume = {1},
number = {1},
pages = {68},
doi = {10.20411/pai.v1i1.100}
}
EUVIMED